Welcome : Guest

IPCA Laboratories Ltd. (India) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about IPCA Laboratories Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 101 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-11000
Price: $3500
Company Type: Public
Pages: 105
Date: January 2017
Market Data Tables: 101

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: IPCA Laboratories Ltd.'s (Operations) Sales by Geographic Region Worldwide (2015-2016) in Percentage for India, and Outside India......5
Table 2: IPCA Laboratories Ltd.'s (Operations) Sales by Geographical Region Worldwide (2014-2015) in Percentage for India and International......6
Active Pharmaceutical Ingredients (API)......7
Table 3: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for In-House Manufacturing, and Outsourced to CMOs......7
Table 4: Generic Active Pharmaceutical Ingredients Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Avapro Avalide, Benicar HCT, Cozaar Hyzaar, Diovan HCT, and Others......8
Table 5: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2015) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)......9
Table 6: Pharmaceuticals Services and Active Ingredients (PSAI) Segment Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America and Rest of the World......10
Table 7: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment in China (2015) - Percentage Share Breakdown by Value Sales for Biomanufacturing, HPAPI Manufacturing, and Small Molecules API Manufacturing......11
Anti-Malaria Treatment......12
Table 8: Anti-Malaria Treatment Market by Therapy in Ghana (2015) - Percentage Share Breakdown by Volume for Artemisinin-based Combination Therapies that are not QAACTs, Artemisinin Monotherapy, Non-Artemisinin Therapy and Quality-assured Artemisinin-based Combination Therapies (QAACTs)......12
Table 9: Anti-Malaria Treatment Market by Therapy in Kenya (2015) - Percentage Share Breakdown by Volume for Artemisinin-based Combination Therapies that are not QAACTs, Artemisinin Monotherapy, Non-Artemisinin Therapy and Quality-assured Artemisinin-based Combination Therapies (QAACTs)......13
Table 10: Anti-Malaria Treatment Market by Therapy in Madagascar (2015) - Percentage Share Breakdown by Volume for Artemisinin-based Combination Therapies that are not QAACTs, Non-Artemisinin Therapy and Quality-assured Artemisinin-based Combination Therapies (QAACTs)......14
Table 11: Anti-Malaria Treatment Market by Therapy in Niger (2015) - Percentage Share Breakdown by Volume for Quality-assured Artemisinin-based Combination Therapies (QAACTs), Artemisinin-based Combination Therapies that are not QAACTs and Non-Artemisinin Therapy......15
Table 12: Anti-Malaria Treatment Market by Therapy in Nigeria (2015) - Percentage Share Breakdown by Volume for Artemisinin Monotherapy, Artemisinin-based Combination Therapies that are not QAACTs, Non-Artemisinin Therapy and Quality-assured Artemisinin-based Combination Therapies (QAACTs)......16
Table 13: Anti-Malaria Treatment Market by Therapy in Tanzania (2015) - Percentage Share Breakdown by Volume for Artemisinin-based Combination Therapies that are not QAACTs, Non-Artemisinin Therapy and Quality-assured Artemisinin-based Combination Therapies (QAACTs)......17
Table 14: Anti-Malaria Treatment Market by Therapy in Uganda (2015) - Percentage Share Breakdown by Volume for Artemisinin-based Combination Therapies that are not QAACTs, Non-Artemisinin Therapy, and Quality-assured Artemisinin-based Combination Therapies (QAACTs)......18
Table 15: Anti-Malaria Treatment Market by Therapy in Zanzibar (2015) - Percentage Share Breakdown by Volume for Quality-assured Artemisinin-based Combination Therapies (QAACTs), Artemisinin-based Combination Therapies that are not QAACTs, Artemisinin Monotherapy and Non-Artemisinin Therapy......19
Antihypertensive Drugs......20
Table 16: Antihypertensive Drugs Market by Product in China (2105) - Percentage Share Breakdown by Value for Angiotensin II Receptor Blockers (ARBs), Beta Blocker, Calcium Channel Blocker and Others......20
Cardiology Therapeutics......21
Table 17: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......21
Table 18: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......22
Table 19: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......23
Diabetes......24
Table 20: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......24
Table 21: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......25
Table 22: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......26
Table 23: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......27
Table 24: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......28
Table 25: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......29
Table 26: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......30
Table 27: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......31
Table 28: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......32
Table 29: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......33
Diabetes Drugs......34
Table 30: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......34
Table 31: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......35
Table 32: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......36
Table 33: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......37
Table 34: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......38
Table 35: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......39
Table 36: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......40
Table 37: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......41
Table 38: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......42
Table 39: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......43
Table 40: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......44
Non-Insulin Anti-Diabetic Drugs......45
Table 41: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......45
Dermatological Drugs......46
Table 42: Dermatological Drug Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Acne, Alopecia, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Skin Cancer, and Skin Infections......46
Table 43: Dermatology Drugs Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......47
Table 44: Dermatology Market by Category in the US (2015) - Percentage Share Breakdown by Value for Genericised, Off-Patent but No Generics, On-Patent, and Others......48
Table 45: Dermal Substitutes Chronic Wound Market by Category in the US (2015) - Percentage Share Breakdown by Value for Diabetic Foot Ulcer, Pressure Ulcer and Venous Leg Ulcer......49
Table 46: Prevalence & Severity of Actinic Keratoses Market by Category in the US (2015) - Percentage Share Breakdown by Value for Minimal, Moderate, Severe, and Others......50
Gastrointestinal Drugs......51
Table 47: Gastrointestinal Market Worldwide (2015) in US$ Million......51
Table 48: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......52
Overactive Bladder (OAB)......53
Table 49: Prevalence of Overactive Bladder (OAB) in Women (Age >18) by Type in the US (2015) - Percentage Market Share Breakdown for Did Not Experience, and Experience......53
Table 50: Prevalence of Overactive Bladder (OAB) in Men (Age >18) by Type in the US (2015) - Percentage Market Share Breakdown for Did Not Experience, and Experience......54
Urology......55
Table 51: Urology Market by Product Segment Worldwide (2015) - Percentage Breakdown by Value for Basic Drainage, Catheter Stabilization, Continence, Temperature Management, and Urological Specialties......55
Table 52: Urology Care Market by Region Worldwide (2015) - Percentage Share Breakdown for Europe, North America, and Rest of World (RoW)......56
Table 53: Urology Market by Category in North America and Europe (2015) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis / Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers......57
Table 54: Urology Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 years, 15-44 Years, 45-64 Years, and 65+ Years......58
Table 55: Urology and Gynaecology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Dialysis Equipment, Gynaecology Devices, Urinary Catheters, and Urology Devices......59
Urinary Incontinence Drugs......60
Table 56: Urinary Incontinence Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......60
Table 57: Urinary Incontinence Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......61
Rheumatoid Arthritis......62
Table 58: Rheumatoid Arthritis Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and Others......62
Formulations......63
Table 59: Formulations Sales by Category in India (2015) - Percentage Market Share Breakdown by Value for Anti Infective, Anti-diabetic, Central Nervous System (CNS), Cyclic Vomiting Syndrome (CVS), Gastrointestinal, Pain Management, and Others......63
Pain Drugs......64
Table 60: Pain Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Hydrocordone, Acetaminophen, Lidoderm, Lyrica, OpanaER, Oxycotin, and Others......64
Respiratory Drugs......65
Table 61: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......65
Table 62: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......66
Neurology......67
Table 63: Neurology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cerebrospinal Fluid Management, Interventional Neuroradiology, Neurostimulation, Neurosurgery, and Neurovascular Catheters......67
Acne Drugs......68
Table 64: Acne Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Isotretinoin, Topicals (Retinoid/Antibiotics), Oral Antibiotics, and Others......68
Table 65: Anti-acne Topical Dermatology Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Acne, AK + Psoriasis + Dermatitis + Others, Anti-Fungal Combo, Anti-Infective, Coagulants, Corticosteroids Combo, and Corticosteroids Plain......69
Table 66: Acne Drugs Market by Segments in the US (2015) - Percentage Share Breakdown by Volume for Orals and Topicals......70
Affordable Medicines Facility Malaria (AMFm)......71
Table 67: Market Shares of Leading Affordable Medicines Facility Malaria (AMFm) Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Ajanta Pharma Limited, Cipla Limited, Ipca Laboratories, Novartis AG, Strides Arcolab Limited, and Others......71
Artemisinin-based Combination Therapies (ACT)......72
Table 68: Market Shares of Leading Artemisinin-based Combination Therapies (ACT) Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Ajanta Pharma Limited, Cipla Limited, Guilin Pharmaceutical Co., Ltd., Ipca Laboratories, Novartis AG, Quality Pharma Products Pvt Ltd., Sanofi S.A., and Sigma Pharmaceuticals Limited......72
Antihypertensive Drugs......73
Table 69: Market Shares of Leading Antihypertensive Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for AstraZeneca, Bayer AG, Novartis International AG, Pfizer, Inc., Sanofi-Aventis and Others......73
Cardiology Therapeutics......74
Table 70: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......74
Diabetes Drugs......75
Table 71: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......75
Table 72: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......76
Table 73: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......77
Dermatological Products......78
Table 74: Market Shares of Leading Dermatological Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......78
Table 75: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......79
Table 76: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......80
Table 77: Market Shares of Leading Drugs for Treatment of Skin Infection in the US (2015) - Percentage Share Breakdown by Value for CUBICIN, VANCOMYCIN, ZYVOX IV and Others......81
Gastrointestinal Drugs......82
Table 78: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......82
Table 79: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......83
Table 80: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over- the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......84
Table 81: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......85
Table 82: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......86
Urinary Incontinence Therapeutics......87
Table 83: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......87
Pain Management Drugs......88
Table 84: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......88
Table 85: Market Shares of Leading Pain Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Bayer HealthCare AG, Johnson & Johnson Private Limited, Pfizer, Inc., Prestige Brands Holdings, Inc., Private-label and Others......89
Table 86: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2014) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......90
Table 87: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others......91
Table 88: Market Shares of Leading Oral Pain Relief Brands through Supermarkets, Drugstores, Mass Merchandisers (including Wal-Mart), Gas & Convenience Stores, Military Commissaries, and Select Club and Dollar Retail Chains in the US (2015) - Percentage Share Breakdown by Value for Anbesol, BabyOrajel, Hyland's, KankA, Orajel, and Others......92
Table 89: Market Shares of Leading Oral Pain Remedy Brands by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Share Breakdown for Anbesol, Baby Orajel, Glyoxide, Kank-A, Orajel, Private Label, and Others......93
Respiratory Therapeutics......94
Table 90: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......94
Acne Drugs......95
Table 91: Market Shares of Leading Branded Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Allergan, Inc., Galderma, Valeant Pharmaceuticals International, Inc. and Others......95
Table 92: Market Shares of Leading Branded Anti-acne Treatement Providers Worldwide (2015) - Percentage Share Breakdown by Value for Allergan, plc, Bayer AG, Galderma S.A., GlaxoSmithKline Pharmaceuticals Ltd., Prasco Laboratories, Valeant Pharmaceuticals International, Inc., and Others......96
Table 93: Market Shares of Leading Generic Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan, Perrigo Company, Pfizer, Inc., Sandoz and Others......97
Table 94: Market Shares of Leading Generic Anti-acne Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan N.V., Perrigo Company plc, Pfizer, Inc., Prasco Laboratories, Rouses Point Pharmaceuticals LLC, Sandoz Inc., Taro Pharmaceutical Industries Ltd., and Private Label......98
Table 95: Topical Prescription Acne Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Cash Payment, Commercial, and Managed Medicaid Payment, Medicare Payment......99
Table 96: Market Shares of Leading Topical Acne Treatment Brands in the US (2015) - Percentage Market Share Breakdown by Volume for Acanya, Aczone, Differin, Epiduo, Finacea, and Others......100
Table 97: Oral Prescription Acne Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Cash Payment, Commercial, and Medicare Payment......101
Table 98: Market Shares of Leading Oral Acne Treatment Brands in the US (2015) - Percentage Market Share Breakdown by Volume for Doryx, Monodox, Oracea, Solodyn, and Others......102
Table 99: Ipca Laboratories Ltd.'s Formulations Sales by Therapy (2015) - Percentage Share Breakdown by Value for Bacterial, Cardio Vascular System & Diabetic, Gastro-intestinal (GI), Malarial, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), and Others......103
Table 100: IPCA Laboratories Ltd.'s (Operations) Sales by Product Segment Worldwide (2013-2014) in Percentage for Sales of Products (Formulations and Active Pharmaceutical Ingredients (APIs) and Intermediates and Other) and Others......104
Table 101: IPCA Laboratories Ltd.'s (Formulations/APIs and Intermediates) Sales by Geographical Region Worldwide (2013-2014) in Percentage for India, Europe, Africa, Americas, Asia, Australasia and CIS......105